Reducing Out-of-pocket Costs of Disease-modifying Therapies for Medicare Part D Beneficiaries with Multiple Sclerosis: A Call to Action for Neurologists (P3-1.004)
To estimate out-of-pocket (OOP) costs for disease-modifying therapies (DMTs) among Medicare Part D beneficiaries with multiple sclerosis (MS) under different scenarios.
Authors
- Salim Chahin (ORCID: https://orcid.org/0000-0002-4115-4300)
- John Kent Lin (ORCID: https://orcid.org/0000-0003-2490-4453)
- Matthew J. Klebanoff (ORCID: https://orcid.org/0000-0002-5081-063X)
- Jalpa A. Doshi (ORCID: https://orcid.org/0000-0002-3263-4337)
- Pengxiang Li (ORCID: https://orcid.org/0000-0002-0795-6684)
- Riya Palkar
Institutions
- The University of Texas MD Anderson Cancer Center (US)
- Washington University in St. Louis (US)
- University of Pennsylvania (US)
Publication Details
- Journal
- Neurology
- Published
- 2025-04-07
- DOI
- https://doi.org/10.1212/wnl.0000000000212388
- Primary Topic
- Health Systems, Economic Evaluations, Quality of Life
- Type
- article
- Field-Weighted Citation Impact
- 0.00